Literature DB >> 2853770

Update in cancer chemotherapy: genitourinary tract cancer, Part 2: Wilms' tumor and bladder cancer.

J C Wright.   

Abstract

An update of the state of the art of cancer chemotherapeutic treatment of genitourinary tract cancer is described in this multi-part series. Included in the review are cancers of the kidney, bladder, prostate, testicle, ovary, uterus, vulva, and gestational trophoblastic neoplasms. Part 2 focuses on Wilms' tumor and bladder cancer.Major advances have been made in the control of Wilms' tumor in children. The combination of surgery, chemotherapy, and radiotherapy have significantly improved survival rates. Likewise, the early diagnosis and control of bladder cancer has also improved survival. Surgery predominates among the treatment modalities for carcinoma of the bladder. Important progress is being made in the control of these conditions, as well as with other tumors of the genitourinary tract, with the use of cancer chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2853770      PMCID: PMC2625724     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  43 in total

1.  Chemotherapy of human solid tumors with 5-fluorouracil.

Authors:  W L WILSON
Journal:  Cancer       Date:  1960 Nov-Dec       Impact factor: 6.860

2.  Advances in chemotherapy of cancer in man.

Authors:  S FARBER; D PINKEL; E M SEARS; R TOCH
Journal:  Adv Cancer Res       Date:  1956       Impact factor: 6.242

3.  EMBRYOMA OF THE KIDNEY (WILMS' TUMOR).

Authors:  W E Ladd
Journal:  Ann Surg       Date:  1938-11       Impact factor: 12.969

4.  Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer.

Authors:  S FARBER
Journal:  Blood       Date:  1949-02       Impact factor: 22.113

5.  The surgical management of bladder carcinoma.

Authors:  G R Prout
Journal:  Urol Clin North Am       Date:  1976-02       Impact factor: 2.241

6.  Phase II trial of sequentially administered cisplatin, cyclophosphamide and doxorubicin for urothelial tract tumors.

Authors:  S Schwartz; A Yagoda; R B Natale; R C Watson; W F Whitmore; M Lesser
Journal:  J Urol       Date:  1983-10       Impact factor: 7.450

7.  High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer.

Authors:  D G Skinner; J P Tift; J J Kaufman
Journal:  J Urol       Date:  1982-04       Impact factor: 7.450

8.  Methotrexate: an active drug in bladder cancer.

Authors:  R B Natale; A Yagoda; R C Watson; W F Whitmore; M Blumenreich; D W Braun
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

9.  Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder.

Authors:  N H Slack; I D Bross; G R Prout
Journal:  J Surg Oncol       Date:  1977       Impact factor: 3.454

10.  A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study.

Authors:  M S Soloway; A Einstein; M P Corder; W Bonney; G R Prout; J Coombs
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

View more
  2 in total

Review 1.  Innovations in the management of Wilms' tumor.

Authors:  Joseph M Gleason; Armando J Lorenzo; Paul R Bowlin; Martin A Koyle
Journal:  Ther Adv Urol       Date:  2014-08

Review 2.  Multidisciplinary Treatment Strategies for Wilms Tumor: Recent Advances, Technical Innovations and Future Directions.

Authors:  Till-Martin Theilen; Yannick Braun; Konrad Bochennek; Udo Rolle; Henning C Fiegel; Florian Friedmacher
Journal:  Front Pediatr       Date:  2022-07-14       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.